| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |